Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Terns Pharmaceuticals (TERN) Leases (2022 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Leases for 2 consecutive years, with $671000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Leases fell 43.8% year-over-year to $671000.0, compared with a TTM value of $671000.0 through Sep 2023, down 43.8%, and an annual FY2022 reading of $1.0 million, changed N/A over the prior year.
  • Leases was $671000.0 for Q3 2023 at Terns Pharmaceuticals, down from $756000.0 in the prior quarter.
  • Across five years, Leases topped out at $1.4 million in Q1 2022 and bottomed at $671000.0 in Q3 2023.